Medical Devices

As a rare Ebola strain rages in a DRC warzone, the G7 pledges massive aid. But with fragile peace deals and no proven cure, is it enough to stop a global crisis?

When a long-term disability claim is denied, the clock starts ticking. Here’s how to understand the insurer's playbook and the legal maze you must navigate.

A new report reveals 9.6 million Americans have sought dental care abroad. This exodus highlights a failing system and a booming global market built on US costs.

New platinum-cured silicone tubing eliminates harmful chemical byproducts, offering medical device makers a faster path to market with superior patient safety.

The acquisition of SprinkGuard by a DelCam portfolio company is no mere transaction. It's a masterclass in building an industrial powerhouse from the ground up.

Vancouver's Svante Technologies wins a top Fast Company award for its nano-filters. This isn't just praise—it's a sign that profitable, scalable carbon capture is here.

Ice Cube's BIG3 league and the PCF are deploying a new playbook, using basketball's cultural power to bring life-saving cancer screenings directly to Black men.

A look at how a Massachusetts ABA provider turns clinical assessments into a viable business blueprint, using expert insights and innovative media to scale trust.

In a strategic pivot, GeneDx brings in former Quest and Thermo Fisher exec Mark Gardner to translate its genomic leadership into commercial dominance.

With patient dosing underway for its fibroblast-based DFU therapy, FibroBiologics is testing a new paradigm: healing chronic wounds from within.

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

A new partnership aims to transform care for thousands of dual-eligible residents, moving specialized palliative services from the hospital to the community.

Leveraging nostalgia and new market data, Crayola is targeting adults with its 'All Grown Up' line. Is this a savvy pivot or a brand identity risk?

Baptist Health's re-accreditation in the Cayman Islands is more than a quality seal. It’s a blueprint for a new economic and healthcare model in the Caribbean.

BioAge Labs starts a Phase 2 trial for BGE-102, an oral drug targeting inflammation to reduce heart risk, a strategy that could redefine cardiovascular care.

The at-home beauty tech giant is betting on immersive, influencer-led wellness events to conquer the US market. Is this the future of brand building?

A guidance cut at Sanuwave reveals a deeper crisis in wound care, driven by CMS policy shifts that are fueling a disruptive secondary equipment market.

A Samsung spin-off is betting that millions of data points and AI can solve skincare’s guessing game. But can it win over consumers and navigate data privacy?

As 'forever chemicals' threaten NC water, PTRWA's new partnership with ROTEC brings cutting-edge filtration tech to safeguard public health and regional growth.

How a small industrial city in China pivoted from chemical production to dominate the $3.8B global smart cat litter market with a high-tech health solution.